More than 100,000 Cologuard tests were completed by the end of 2015, but Exact Sciences expects the number of its stool DNA-based colorectal cancer screening tests completed in 2016 will more than double, according to a Post Bulletin report.
In addition to the growth in tests performed, Exact Sciences, based in Madison, Wis., is planning to build a new location in Madison. The $200 million project, which includes $46.7 million in public investment, is expected to add 400 jobs to the city, according to the report. Exact Sciences currently has more than 700 employees, with 275 hired in 2015.